BioHarvest Sciences Inc. announced on May 21, 2025, that its Botanical Synthesis CDMO Services division secured a new contract to develop a plant-based fragrance compound. This agreement with an undisclosed commercial partner marks the company's entry into the multi-billion-dollar fragrance and scents market.
The contract targets a compound derived from a threatened plant species facing overharvesting and habitat loss. BioHarvest utilized its AI-assisted research platform to identify the specific plant species most likely to yield a viable cell bank for future production.
The Stage 1 agreement involves replicating and multiplying the plant's fragrance-producing cells in laboratory petri dishes using the proprietary Botanical Synthesis platform. A successful outcome in Stage 1 could lead to Stage 2, involving liquid media production, a step towards potential volume manufacturing and commercialization.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.